Effectiveness and Safety of Omalizumab in Children With Allergic Asthma.
Clinical trial NCT05424523 · COMPLETED
Trial details
- NCT number
- NCT05424523
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-02-25
- Primary completion
- 2021-06-28
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.